Skip to main content
Premium Trial:

Request an Annual Quote

Applera Files Complaint, Notice of Arbitration Against Roche Over PCR Technology

NEW YORK, Oct. 13 (GenomeWeb News) - Applera said today that it has filed a complaint in California Superior Court, county of San Mateo, relating to disputes with Hoffman-La Roche and some of its subsidiaries over PCR technology.

 

Applera also said that that, in a separate action involving Roche, it has filed a notice of arbitration with the American Arbitration Association.

 

"Rights to PCR are part of the intellectual property estate of Applera," Applied Biosystems president Michael Hunkapiller said in a statement. "With these actions, Applera is seeking to protect its rights to PCR and obtain fair value from these rights."

 

Applera has licenses from Roche to certain PCR intellectual property, and markets TaqMan products that use Roche-designed PCR technology.

 

An Applera spokeswoman declined to comment on the matter.  Officials from Roche were unavailable.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.